Susquehanna International Group, LLP Cytek Biosciences, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 17,004 shares of CTKB stock, worth $107,465. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,004
Previous 92,784
81.67%
Holding current value
$107,465
Previous $517,000
81.82%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CTKB
# of Institutions
134Shares Held
71.7MCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$108 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$74.4 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD9.49MShares$60 Million1.15% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$42.1 Million0.85% of portfolio
-
State Street Corp Boston, MA4.17MShares$26.3 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $851M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...